CRLF2 and acute lymphoblastic leukemia: Cox model analysis of the two cohorts analyzed together, adjusted by risk group, showed that CRLF2-high expression is an independent prognostic factor in T-ALL, associated with a 2.5-fold increased risk of relapse.